Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of the American Chemical Society
|
October 3, 2002
Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors
Natalie A Dales, Alexandra E Gould, James A Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 19, 2004
Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R)
Thomas H Marsilje, Jonathan B Roses, Emily F Calderwood, et al.
Journal of Medicinal Chemistry
|
October 18, 2011
Antibacterial optimization of 4-aminothiazolyl analogues of the natural product GE2270 A: identification of the cycloalkylcarboxylic acids
Matthew J LaMarche, Jennifer A Leeds, Kerri Amaral, et al.
Journal of Medicinal Chemistry
|
March 19, 2004
Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model
Tricia J Vos, Andrei Caracoti, Jennifer L Che, et al.
Journal of Medicinal Chemistry
|
June 30, 2016
Antibacterial and Solubility Optimization of Thiomuracin A
Matthew J LaMarche, Jennifer A Leeds, Jason Brewer, et al.
Antimicrobial Agents and Chemotherapy
|
August 10, 2011
In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu
J A Leeds, M J LaMarche, J T Brewer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonists
Anil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.
Journal of Medicinal Chemistry
|
February 10, 2012
Discovery of LFF571: an investigational agent for Clostridium difficile infection
Matthew J LaMarche, Jennifer A Leeds, Adam Amaral, et al.
Nature
|
May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of the American Chemical Society
|
October 3, 2002
Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors
Natalie A Dales, Alexandra E Gould, James A Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 19, 2004
Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R)
Thomas H Marsilje, Jonathan B Roses, Emily F Calderwood, et al.
Journal of Medicinal Chemistry
|
October 18, 2011
Antibacterial optimization of 4-aminothiazolyl analogues of the natural product GE2270 A: identification of the cycloalkylcarboxylic acids
Matthew J LaMarche, Jennifer A Leeds, Kerri Amaral, et al.
Journal of Medicinal Chemistry
|
March 19, 2004
Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model
Tricia J Vos, Andrei Caracoti, Jennifer L Che, et al.
Journal of Medicinal Chemistry
|
June 30, 2016
Antibacterial and Solubility Optimization of Thiomuracin A
Matthew J LaMarche, Jennifer A Leeds, Jason Brewer, et al.
Antimicrobial Agents and Chemotherapy
|
August 10, 2011
In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu
J A Leeds, M J LaMarche, J T Brewer, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonists
Anil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.
Journal of Medicinal Chemistry
|
February 10, 2012
Discovery of LFF571: an investigational agent for Clostridium difficile infection
Matthew J LaMarche, Jennifer A Leeds, Adam Amaral, et al.
Nature
|
May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.
Page
of 3